Fibrin-stabilizing factor inhibitors. 12. 5-Dibenzylaminopentylamine and related compounds, a new type of FSF inhibitors.
A series of omegadibenzylaminoalkylamines and related compounds have been prepared and tested as inhibitors of fibrin cross-linking. This structural type was chosen in an attempt to develop noncompetitive inhibitors of fibrinoligase. By the combination of the dibenzylamino moiety at one end and the primary amino group at the other end of a polymethylene chain, the same compound could function both as a pseudo donor substrate and as a noncompetitive alkylating inhibitor. Some of the compounds, notably 74-79, are among the most active fibrinoligase inhibitors described. However, the data indicate that the compounds probably function only as pseudo donor inhibitors.
D001593:Benzyl Compounds / Q000138:chemical synthesis / Q000494:pharmacology; D002103:Cadaverine / Q000494:pharmacology; D003619:Dansyl Compounds; D003959:Diamines / Q000138:chemical synthesis* / Q000494:pharmacology; D005176:Factor XIII / Q000037:antagonists & inhibitors*; D066298:In Vitro Techniques; D013329:Structure-Activity Relationship
D001593:Benzyl Compounds; D003619:Dansyl Compounds; D003959:Diamines; D005176:Factor XIII; D002103:Cadaverine